CORE
Expectation alignment before consent
Behaviorally structured content that translates protocol complexity into daily-life terms. Visit logistics, side effect profiles, caregiver requirements made explicit before signature.
Motivated patients,
overwhelmed by complexity.
Oncology. Dermatology. Ophthalmology. Neurology.Disease severity creates urgency.Protocol complexity threatens completion.
The readiness profile.
High motivation but high burden. Complex medication regimens that require precise timing and monitoring. Frequent site visits that disrupt daily life and employment. Side effect profiles that patients underestimate at consent.
Caregiver burden is a hidden variable. The patient may be ready, but if the caregiver cannot sustain the support structure across complex visit schedules, side effect management, and emotional labor, participation collapses. Specialty trials need both patient readiness and caregiver readiness validated before consent.
Where dropout concentrates.
Early participation. The period when protocol reality exceeds pre-enrollment expectations.
The patient consented based on an understanding of the treatment, but the operational demands of participation were underestimated or poorly communicated. The gap between what was expected and what is required triggers early withdrawal. By the time it surfaces, the trial has spent screening resources, site time, and study medication on a patient who never had a sustainable participation plan.
What CORE and PRISM govern in specialty trials.
CORE makes the protocol's full reality understandable before consent. PRISM validates that both the patient and the caregiver can sustain it.
CORE
Caregiver-inclusive education
Caregiver-specific content addressing role definition, burden translation, and decision partnership. Calibrated to health literacy level and family structure.
PRISM
Burden feasibility modeling
Pre-enrollment validation of whether the patient's life structure can sustain protocol demands. Travel, time, employment, side effect tolerance, caregiver bandwidth modeled explicitly.
PRISM
Comprehension-validated advancement
Patients advance to consent only when both treatment understanding and logistical capacity are validated. Sites receive prepared patients, not motivated ones who cannot sustain participation.
An oncology patient who consents to a 24-cycle immunotherapy trial often understands the treatment but not the logistics. Visit schedules, transportation, side effect management between cycles, caregiver time commitment. CORE explains both. PRISM validates both. Understanding the drug is necessary. Understanding the protocol is what determines completion.
Frequently Asked Questions
How does protocol complexity affect specialty-disease trial retention?
Patients in specialty disease trials are motivated. Disease severity creates urgency. But protocols are complex: frequent visits, invasive procedures, side effect management, caregiver coordination. The readiness challenge is not motivation, it is cognitive and logistical friction that overwhelms even willing participants.
What role does caregiver readiness play in specialty trials?
Caregiver burden is a hidden variable. The patient may be ready, but if the caregiver cannot sustain the support structure across complex visit schedules, side effect management, and emotional labor, participation collapses. CORE and PRISM treat caregiver readiness as a distinct variable validated alongside patient readiness.
What does CORE produce for a specialty trial?
Patient and caregiver websites, explainer videos, brochures, HCP and site materials that translate protocol complexity into daily-life terms. Burden translation, visit logistics, side effect profiles, caregiver role definition. Multilingual and amendment-resilient.
How does PRISM validate burden feasibility?
Pre-enrollment, PRISM scores each eligible patient on their capacity to sustain the protocol. Travel distance, employment constraints, caregiver bandwidth, side effect tolerance. Patients advance only when both treatment comprehension and logistical capacity meet readiness thresholds.
Send us your protocol and site list.
In two days, you get three execution diagnostics on your program.
01 · The Baseline
Trial Readiness Index
How likely each eligible patient cluster is to activate, persist, and complete, before any intervention.
02 · The Diagnosis
Readiness Friction Map
The barriers most likely to suppress activation, enrollment, and completion in each cluster, and how to mitigate them.
03 · The Prescription
Readiness
Blueprint
Which clusters to target, which barriers to address, which interventions to deploy, and what completion lift to expect.